000 | 01833 a2200565 4500 | ||
---|---|---|---|
005 | 20250514000751.0 | ||
264 | 0 | _c20010705 | |
008 | 200107s 0 0 eng d | ||
022 | _a0741-5400 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerland, C | |
245 | 0 | 0 |
_aEotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. _h[electronic resource] |
260 |
_bJournal of leukocyte biology _cMay 2001 |
||
300 |
_a772-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aArachidonic Acids _xmetabolism |
650 | 0 | 4 |
_aAsthma _xblood |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 | _aChemokine CCL11 |
650 | 0 | 4 | _aChemokines, CC |
650 | 0 | 4 |
_aChemotactic Factors, Eosinophil _xmetabolism |
650 | 0 | 4 | _aCollagen |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aEosinophils _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolysin _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aLaminin |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
650 | 0 | 4 |
_aPlasminogen _xmetabolism |
650 | 0 | 4 |
_aPlatelet Activating Factor _xmetabolism |
650 | 0 | 4 | _aProteoglycans |
650 | 0 | 4 | _aReceptors, CCR3 |
650 | 0 | 4 |
_aReceptors, Cell Surface _xbiosynthesis |
650 | 0 | 4 |
_aReceptors, Chemokine _xbiosynthesis |
650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
700 | 1 | _aGuilbert, M | |
700 | 1 | _aDavoine, F | |
700 | 1 | _aFlamand, N | |
700 | 1 | _aChakir, J | |
700 | 1 | _aLaviolette, M | |
773 | 0 |
_tJournal of leukocyte biology _gvol. 69 _gno. 5 _gp. 772-8 |
|
999 |
_c11291059 _d11291059 |